Breast cancer expression of E-cadherin does not differ between patients with positive and negative oncological history
The question of whether or not non-sporadic breast malignancies have different immunohistochemical features than sporadic malignancies has not been investigated previously. Consequently, the purpose of this study was to compare the expression of E-cadherin (EC) in breast cancer patients with positiv...
Gespeichert in:
| Veröffentlicht in: | Advances in medical sciences 2008, Vol.53 (2), p.251-255 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 255 |
|---|---|
| container_issue | 2 |
| container_start_page | 251 |
| container_title | Advances in medical sciences |
| container_volume | 53 |
| creator | Bruzewicz, S Matkowski, R Swiatoniowski, G Suder, E Setta, M Połozowski, A Zychowicz, K Szynglarewicz, B Kornafel, J |
| description | The question of whether or not non-sporadic breast malignancies have different immunohistochemical features than sporadic malignancies has not been investigated previously. Consequently, the purpose of this study was to compare the expression of E-cadherin (EC) in breast cancer patients with positive and negative oncologic histories.
The study included 98 breast cancer patients divided into two groups: 1) without the personal or familial history of previous malignancies, and 2) with the personal history of previous malignancies and/or with the data on cancer episodes in first- and/or second-degree relatives.
There were no significant differences in the expression of EC between breast malignancies of the two groups. Moreover, statistical relationships were not observed between the positive or negative oncologic history, the age, and the menopausal status of patients, or histological tumor grade.
Although the results of our series revealed no significant differences in the expression of EC between assumed sporadic and assumed non-sporadic malignancies, there is a need for further comparative studies on the immunohistochemistry of both the breast carcinoma types in order to find the other biological markers that could suggest or exclude cancer susceptibility in a given patient. Nevertheless, the results of our study suggest that EC immunohistochemistry cannot be used as a surrogate marker for screening for hereditary breast cancer. |
| doi_str_mv | 10.2478/v10039-008-0007-y |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69909714</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2929184651</sourcerecordid><originalsourceid>FETCH-LOGICAL-c279t-ce62471842130adc551ab7c959d253e66d8931d7bf83f0d4ed838d59fefa2afd3</originalsourceid><addsrcrecordid>eNpdkU1rXCEUhqU0NB_tD-imCIXubuPHvX4s25A2hUA26VocPWYMd_RWnUnm39dkBgpdiB54zuE9Pgh9pOQrG6W63FFCuB4IUf0QOezfoDOqtBpGQtjb17cYKGXiFJ3X-kiIYIKQd-iUqlFIJskZ2n0vYGvDziYHBcPzUqDWmBPOAV8Pzvo1lJiwz1Bxyg37GEIHV9CeABJebIuQWsVPsa3xkmtscQfYJo8TPNjXIieX5_wQnZ3xOtaWy_49Ogl2rvDheF-g3z-u769uhtu7n7-uvt0OjkndBgeiL9rTMsqJ9W6aqF1Jpyft2cRBCK80p16uguKB-BG84spPOkCwzAbPL9CXw9yl5D9bqM1sYnUwzzZB3lYjtCZa0rGDn_8DH_O2pJ7NUM76H3JJZKfogXIl11ogmKXEjS17Q4l5UWIOSkxXYl6UmH3v-XScvF1twP_rODrgfwGJuIk7</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1321123707</pqid></control><display><type>article</type><title>Breast cancer expression of E-cadherin does not differ between patients with positive and negative oncological history</title><source>MEDLINE</source><source>ProQuest Central UK/Ireland</source><source>Alma/SFX Local Collection</source><creator>Bruzewicz, S ; Matkowski, R ; Swiatoniowski, G ; Suder, E ; Setta, M ; Połozowski, A ; Zychowicz, K ; Szynglarewicz, B ; Kornafel, J</creator><creatorcontrib>Bruzewicz, S ; Matkowski, R ; Swiatoniowski, G ; Suder, E ; Setta, M ; Połozowski, A ; Zychowicz, K ; Szynglarewicz, B ; Kornafel, J</creatorcontrib><description>The question of whether or not non-sporadic breast malignancies have different immunohistochemical features than sporadic malignancies has not been investigated previously. Consequently, the purpose of this study was to compare the expression of E-cadherin (EC) in breast cancer patients with positive and negative oncologic histories.
The study included 98 breast cancer patients divided into two groups: 1) without the personal or familial history of previous malignancies, and 2) with the personal history of previous malignancies and/or with the data on cancer episodes in first- and/or second-degree relatives.
There were no significant differences in the expression of EC between breast malignancies of the two groups. Moreover, statistical relationships were not observed between the positive or negative oncologic history, the age, and the menopausal status of patients, or histological tumor grade.
Although the results of our series revealed no significant differences in the expression of EC between assumed sporadic and assumed non-sporadic malignancies, there is a need for further comparative studies on the immunohistochemistry of both the breast carcinoma types in order to find the other biological markers that could suggest or exclude cancer susceptibility in a given patient. Nevertheless, the results of our study suggest that EC immunohistochemistry cannot be used as a surrogate marker for screening for hereditary breast cancer.</description><identifier>ISSN: 1896-1126</identifier><identifier>EISSN: 1898-4002</identifier><identifier>DOI: 10.2478/v10039-008-0007-y</identifier><identifier>PMID: 18467270</identifier><language>eng</language><publisher>Netherlands: Elsevier Limited</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms - diagnosis ; Breast Neoplasms - metabolism ; Cadherins - metabolism ; Carcinoma, Ductal, Breast - diagnosis ; Carcinoma, Ductal, Breast - metabolism ; Female ; Genetic Predisposition to Disease ; Humans ; Immunoenzyme Techniques ; Middle Aged ; Neoplasm Staging</subject><ispartof>Advances in medical sciences, 2008, Vol.53 (2), p.251-255</ispartof><rights>Copyright Versita 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c279t-ce62471842130adc551ab7c959d253e66d8931d7bf83f0d4ed838d59fefa2afd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1321123707?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,776,780,4009,27902,27903,27904,64361,64363,64365,72215</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18467270$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bruzewicz, S</creatorcontrib><creatorcontrib>Matkowski, R</creatorcontrib><creatorcontrib>Swiatoniowski, G</creatorcontrib><creatorcontrib>Suder, E</creatorcontrib><creatorcontrib>Setta, M</creatorcontrib><creatorcontrib>Połozowski, A</creatorcontrib><creatorcontrib>Zychowicz, K</creatorcontrib><creatorcontrib>Szynglarewicz, B</creatorcontrib><creatorcontrib>Kornafel, J</creatorcontrib><title>Breast cancer expression of E-cadherin does not differ between patients with positive and negative oncological history</title><title>Advances in medical sciences</title><addtitle>Adv Med Sci</addtitle><description>The question of whether or not non-sporadic breast malignancies have different immunohistochemical features than sporadic malignancies has not been investigated previously. Consequently, the purpose of this study was to compare the expression of E-cadherin (EC) in breast cancer patients with positive and negative oncologic histories.
The study included 98 breast cancer patients divided into two groups: 1) without the personal or familial history of previous malignancies, and 2) with the personal history of previous malignancies and/or with the data on cancer episodes in first- and/or second-degree relatives.
There were no significant differences in the expression of EC between breast malignancies of the two groups. Moreover, statistical relationships were not observed between the positive or negative oncologic history, the age, and the menopausal status of patients, or histological tumor grade.
Although the results of our series revealed no significant differences in the expression of EC between assumed sporadic and assumed non-sporadic malignancies, there is a need for further comparative studies on the immunohistochemistry of both the breast carcinoma types in order to find the other biological markers that could suggest or exclude cancer susceptibility in a given patient. Nevertheless, the results of our study suggest that EC immunohistochemistry cannot be used as a surrogate marker for screening for hereditary breast cancer.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Breast Neoplasms - diagnosis</subject><subject>Breast Neoplasms - metabolism</subject><subject>Cadherins - metabolism</subject><subject>Carcinoma, Ductal, Breast - diagnosis</subject><subject>Carcinoma, Ductal, Breast - metabolism</subject><subject>Female</subject><subject>Genetic Predisposition to Disease</subject><subject>Humans</subject><subject>Immunoenzyme Techniques</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><issn>1896-1126</issn><issn>1898-4002</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdkU1rXCEUhqU0NB_tD-imCIXubuPHvX4s25A2hUA26VocPWYMd_RWnUnm39dkBgpdiB54zuE9Pgh9pOQrG6W63FFCuB4IUf0QOezfoDOqtBpGQtjb17cYKGXiFJ3X-kiIYIKQd-iUqlFIJskZ2n0vYGvDziYHBcPzUqDWmBPOAV8Pzvo1lJiwz1Bxyg37GEIHV9CeABJebIuQWsVPsa3xkmtscQfYJo8TPNjXIieX5_wQnZ3xOtaWy_49Ogl2rvDheF-g3z-u769uhtu7n7-uvt0OjkndBgeiL9rTMsqJ9W6aqF1Jpyft2cRBCK80p16uguKB-BG84spPOkCwzAbPL9CXw9yl5D9bqM1sYnUwzzZB3lYjtCZa0rGDn_8DH_O2pJ7NUM76H3JJZKfogXIl11ogmKXEjS17Q4l5UWIOSkxXYl6UmH3v-XScvF1twP_rODrgfwGJuIk7</recordid><startdate>2008</startdate><enddate>2008</enddate><creator>Bruzewicz, S</creator><creator>Matkowski, R</creator><creator>Swiatoniowski, G</creator><creator>Suder, E</creator><creator>Setta, M</creator><creator>Połozowski, A</creator><creator>Zychowicz, K</creator><creator>Szynglarewicz, B</creator><creator>Kornafel, J</creator><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BYOGL</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>2008</creationdate><title>Breast cancer expression of E-cadherin does not differ between patients with positive and negative oncological history</title><author>Bruzewicz, S ; Matkowski, R ; Swiatoniowski, G ; Suder, E ; Setta, M ; Połozowski, A ; Zychowicz, K ; Szynglarewicz, B ; Kornafel, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c279t-ce62471842130adc551ab7c959d253e66d8931d7bf83f0d4ed838d59fefa2afd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Breast Neoplasms - diagnosis</topic><topic>Breast Neoplasms - metabolism</topic><topic>Cadherins - metabolism</topic><topic>Carcinoma, Ductal, Breast - diagnosis</topic><topic>Carcinoma, Ductal, Breast - metabolism</topic><topic>Female</topic><topic>Genetic Predisposition to Disease</topic><topic>Humans</topic><topic>Immunoenzyme Techniques</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bruzewicz, S</creatorcontrib><creatorcontrib>Matkowski, R</creatorcontrib><creatorcontrib>Swiatoniowski, G</creatorcontrib><creatorcontrib>Suder, E</creatorcontrib><creatorcontrib>Setta, M</creatorcontrib><creatorcontrib>Połozowski, A</creatorcontrib><creatorcontrib>Zychowicz, K</creatorcontrib><creatorcontrib>Szynglarewicz, B</creatorcontrib><creatorcontrib>Kornafel, J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>East Europe, Central Europe Database</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Advances in medical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bruzewicz, S</au><au>Matkowski, R</au><au>Swiatoniowski, G</au><au>Suder, E</au><au>Setta, M</au><au>Połozowski, A</au><au>Zychowicz, K</au><au>Szynglarewicz, B</au><au>Kornafel, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Breast cancer expression of E-cadherin does not differ between patients with positive and negative oncological history</atitle><jtitle>Advances in medical sciences</jtitle><addtitle>Adv Med Sci</addtitle><date>2008</date><risdate>2008</risdate><volume>53</volume><issue>2</issue><spage>251</spage><epage>255</epage><pages>251-255</pages><issn>1896-1126</issn><eissn>1898-4002</eissn><abstract>The question of whether or not non-sporadic breast malignancies have different immunohistochemical features than sporadic malignancies has not been investigated previously. Consequently, the purpose of this study was to compare the expression of E-cadherin (EC) in breast cancer patients with positive and negative oncologic histories.
The study included 98 breast cancer patients divided into two groups: 1) without the personal or familial history of previous malignancies, and 2) with the personal history of previous malignancies and/or with the data on cancer episodes in first- and/or second-degree relatives.
There were no significant differences in the expression of EC between breast malignancies of the two groups. Moreover, statistical relationships were not observed between the positive or negative oncologic history, the age, and the menopausal status of patients, or histological tumor grade.
Although the results of our series revealed no significant differences in the expression of EC between assumed sporadic and assumed non-sporadic malignancies, there is a need for further comparative studies on the immunohistochemistry of both the breast carcinoma types in order to find the other biological markers that could suggest or exclude cancer susceptibility in a given patient. Nevertheless, the results of our study suggest that EC immunohistochemistry cannot be used as a surrogate marker for screening for hereditary breast cancer.</abstract><cop>Netherlands</cop><pub>Elsevier Limited</pub><pmid>18467270</pmid><doi>10.2478/v10039-008-0007-y</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1896-1126 |
| ispartof | Advances in medical sciences, 2008, Vol.53 (2), p.251-255 |
| issn | 1896-1126 1898-4002 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69909714 |
| source | MEDLINE; ProQuest Central UK/Ireland; Alma/SFX Local Collection |
| subjects | Adult Aged Aged, 80 and over Breast Neoplasms - diagnosis Breast Neoplasms - metabolism Cadherins - metabolism Carcinoma, Ductal, Breast - diagnosis Carcinoma, Ductal, Breast - metabolism Female Genetic Predisposition to Disease Humans Immunoenzyme Techniques Middle Aged Neoplasm Staging |
| title | Breast cancer expression of E-cadherin does not differ between patients with positive and negative oncological history |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T23%3A30%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Breast%20cancer%20expression%20of%20E-cadherin%20does%20not%20differ%20between%20patients%20with%20positive%20and%20negative%20oncological%20history&rft.jtitle=Advances%20in%20medical%20sciences&rft.au=Bruzewicz,%20S&rft.date=2008&rft.volume=53&rft.issue=2&rft.spage=251&rft.epage=255&rft.pages=251-255&rft.issn=1896-1126&rft.eissn=1898-4002&rft_id=info:doi/10.2478/v10039-008-0007-y&rft_dat=%3Cproquest_cross%3E2929184651%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1321123707&rft_id=info:pmid/18467270&rfr_iscdi=true |